DIOVAN 320MG

DIOVAN 320mg is now available as a one a day tablet, doubling the previous highest strength of 160mg. It is found that by doubling the daily dose from 160mg to 320mg reduces the Systolic BP by additional 20% which improves survival. Diovan is the first ARB approved for both reducing BP and CV mortality in cases where patients are suffering from both left ventricular dysfunction (LVD) and acute myocardial infarction when ACEI is inappropriate. Diovan can be used in patients with mild to moderate liver diseases and renal impairment.